The Illinois Biotechnology Innovation Organization (iBIO) today announced the honorees of the thirteenth annual iCON Awards – the region’s most prestigious honor for life sciences educators, researchers and civic visionaries. The iCON Awards celebrate the accomplishments of outstanding innovators and leaders whose work provides the basis for life sciences developments worldwide.

Professor Martin Burke will receive the 2019 iCON Innovator Award at the iCON Award Dinner on September 26, 2019. This award recognizes those scientists who demonstrate leadership potential at the frontier of knowledge in the life sciences and conduct research that is anticipated to enhance economic development in the State of Illinois.

Dr. Burke’s group has pioneered the field of molecular prosthetics, including the development of an automated Lego-like platform for democratizing small molecule synthesis. Dr. Burke has received a number of honors and awards, including the Nobel Laureate Signature Award for Graduate Education in Chemistry from the American Chemical Society and has garnered praise for excellence in teaching at both the undergraduate and graduate levels. Dr. Burke is also the founder of four biotechnology companies: REVOLUTION Medicines, Ambys Medicines, Sfunga Therapeutics and Cystetic Medicines.

“Illinois is one of America’s leading research universities, and Dr. Burke truly is one of our campus icons. Whether developing a new way to synthesize molecules, creating a network of maker labs on campus, launching a company, or encouraging students to think creatively about the future, Dr. Burke’s persistence and energy are remarkable—and contagious! He exemplifies the spirit of innovation that is a hallmark of Illinois research, and we are proud of his many contributions to the broader scientific community and to the state, the nation, and the world,” said Susan A. Martinis, Interim Chancellor for Research, University of Illinois.

Excerpt from Business Wire